BrainTale: Braintale : to Showcase Data on Exploratory Sub-study of Minoryx's Pivotal ADVANCE Phase 2/3 Study at 33rd ENRS Conference

(marketscreener.com) Braintale, an innovative company dedicated to neurological disorders and management of brain injured patients with its portfolio of solutions in neurology and intensive care today announced a poster showcasing data from the exploratory sub-study of Minoryx's ADVANCE phase 2/3 clinical study on clinical benefits of leriglitazone in...https://www.marketscreener.com/news/latest/Braintale-to-Showcase-Data-on-Exploratory-Sub-study-of-Minoryx-s-Pivotal-ADVANCE-Phase-2-3-Study-a--36226717/?utm_medium=RSS&utm_content=20210823